down arrow

China Biotech Services Holdings Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BMG2152F1014
HKD
0.69
-0.06 (-8.0%)

Apr 02

HKG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Lee's Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical Holdings Ltd.
TOT BIOPHARM International Co. Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Charmacy Pharmaceutical Co., Ltd.
Antengene Corp. Ltd.
Clover Biopharmaceuticals Ltd.
China Biotech Services Holdings Ltd.
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.
Lansen Pharmaceutical Holdings Ltd.
Fusen Pharmaceutical Co., Ltd.

Why is China Biotech Services Holdings Ltd. ?

1
Poor long term growth as Operating profit has grown by an annual rate -165.81% of over the last 5 years
2
The company has declared Negative results for the last 4 consecutive quarters
  • INTEREST(HY) At HKD 12.54 MM has Grown at 167.52%
  • OPERATING CASH FLOW(Y) Lowest at HKD -280.51 MM
  • DEBT-EQUITY RATIO (HY) Highest at 84.6 %
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 72.50%, its profits have fallen by -61.9%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is China Biotech Services Holdings Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
China Biotech Services Holdings Ltd.
72.5%
0.91
92.80%
Hang Seng Hong Kong
8.25%
0.41
19.93%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0.74%
EBIT Growth (5y)
-165.81%
EBIT to Interest (avg)
-12.40
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.58
Sales to Capital Employed (avg)
0.21
Tax Ratio
1.50%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
107.26%
ROE (avg)
397.22%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.33
EV to EBIT
-29.83
EV to EBITDA
-31.15
EV to Capital Employed
2.82
EV to Sales
11.71
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-9.47%
ROE (Latest)
-22.32%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
NET PROFIT(HY)

Higher at HKD -36.89 MM

PRE-TAX PROFIT(Q)

At HKD -42.04 MM has Grown at 62.98%

-10What is not working for the Company
INTEREST(HY)

At HKD 12.54 MM has Grown at 167.52%

OPERATING CASH FLOW(Y)

Lowest at HKD -280.51 MM

DEBT-EQUITY RATIO (HY)

Highest at 84.6 %

RAW MATERIAL COST(Y)

Grown by 83.02% (YoY

CASH AND EQV(HY)

Lowest at HKD 11.29 MM

Here's what is working for China Biotech Services Holdings Ltd.

Net Profit
Higher at HKD -36.89 MM
than preceding 12 month period ended Jun 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (HKD MM)

Pre-Tax Profit
At HKD -42.04 MM has Grown at 62.98%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Here's what is not working for China Biotech Services Holdings Ltd.

Interest
At HKD 12.54 MM has Grown at 167.52%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Debt-Equity Ratio
Highest at 84.6 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Cash Flow
Lowest at HKD -280.51 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Cash and Eqv
Lowest at HKD 11.29 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost
Grown by 83.02% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."